Corporate News 20-Jan-23
Laurus Labs receives Establishment Inspection Report for its Visakhapatnam unit
Laurus Labs has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA) following the Pre-Approval Inspection (PAI) conducted by the USFDA at its manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh from 24 October 2022 to 28 October 2022.
Previous News
Laurus Labs fixes record date for 2nd interim dividend
( Market Beat - Reports 25-Apr-24 15:38 )
Laurus Labs Ltd up for third straight session
( Hot Pursuit - 22-May-24 13:05 )
Laurus Labs
( Results - Analysis 24-Jan-24 17:06 )
Board of Laurus Labs recommends Second Interim Dividend
( Corporate News - 25-Apr-24 15:31 )
Laurus Labs fixes record date for interim dividend
( Market Beat - Reports 20-Oct-23 17:57 )
Laurus Labs consolidated net profit declines 26.58% in the March 2024 quarter
( Results - Announcements 25-Apr-24 15:45 )
Laurus Labs director resigns
( Corporate News - 20-Oct-23 18:03 )
Laurus Labs slides after Q4 PAT tumbles 26% YoY to 76 cr
( Hot Pursuit - 25-Apr-24 16:33 )
Laurus Labs Ltd rises for third consecutive session
( Hot Pursuit - 02-Apr-24 13:05 )
Laurus Labs consolidated net profit declines 84.13% in the September 2023 quarter
( Results - Announcements 20-Oct-23 17:54 )
Laurus Labs AGM scheduled
( Corporate News - 25-Apr-24 17:01 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top